Functional implications for modulating neuropeptide Y gene expression in the dorsomedial hypothalamus

Journal of Neuroscience

Volumn 29, Issue 23, 2009, Pages 7389-7391

  Kinzeler, Nicole R ^a,b   Edwards, Kristin S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Postle Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y;

BRAIN NERVE CELL; FOOD INTAKE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HYPOTHALAMUS; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANIMALS; BODY WEIGHT; FEEDING BEHAVIOR; GENE EXPRESSION; HYPOTHALAMUS, MIDDLE; NEUROPEPTIDE Y;

EID: 67049167160     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1647-09.2009     Document Type: Note

References (11)

1. Bi S, Robinson BM, Moran TH (2003) Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression. Am J Physiol Regul Integr Comp Physiol 285:R1030-R1036. (Pubitemid 37296354)
2. Erondu N, Gantz I, Musser B, Suryawanshi S, Mallick M, Addy C, Cote J, Bray G, Fujioka K, Bays H, Hollander P, Sanabria-Bohórquez SM, Eng W, Långström B, Hargreaves RJ, Burns HD, Kanatani A, Fukami T, MacNeil DJ, Gottesdiener KM, et al. (2006) Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab 4:275-282. (Pubitemid 44430911)
3. Gehlert DR (1999) Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides 33:329-338. (Pubitemid 29530125)
4. Giraudo SQ, Grace MK, Billington CJ, Levine AS (1999) Differential effects of neuropeptide Y and the mu-agonist DAMGO on 'palatability' vs. 'energy.' Brain Res 834:160-163.
5. Kamiji MM, Inui A (2007) NPY Y2 and Y4 receptors selective ligands: promising antiobesity drugs? Curr Top Med Chem 7:1734-1742.
6. Kovacs P, Hajnal A (2008) Altered pontine taste processing in a rat model of obesity. J Neurophysiol 100:2145-2157.
7. Levine AS, Kotz CM, Gosnell BA (2003) Sugars: hedonic aspects, neuroregulation, and energy balance. Am J Clin Nutr 78:834S-842S.
8. MacNeil DJ (2007) NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs. Curr Top Med Chem 7:1721-1733. (Pubitemid 350131009)
9. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189-1192. (Pubitemid 17226746)
10. Warrington KH Jr, Herzog RW (2006) Treatment of human disease by adeno-associated viral gene transfer. Hum Genet 119:571-603. (Pubitemid 43805835)
11. Yang L, Scott KA, Hyun J, Tamashiro KL, Tray N, Moran TH, Bi S (2009) Role of dorsomedial hypothalamic neuropeptide Y in modulating food intake and energy balance. J Neurosci 29:179-190.